Publications

Found 385 results
2016
Sok D, Pauthner M, Briney B, Lee J H, Saye-Francisco KL, Hsueh J, Ramos A, Le KM, Jones M, Jardine JG et al..  2016.  A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans.. Immunity. 45(1):31-45.
Deruaz M, Moldt B, Le KM, Power KA, Vrbanac VD, Tanno S, Ghebremichael MS, Allen TM, Tager AM, Burton DR et al..  2016.  Protection of Humanized Mice From Repeated Intravaginal HIV Challenge by Passive Immunization: A Model for Studying the Efficacy of Neutralizing Antibodies In Vivo.. J Infect Dis. 214(4):612-6.
Abbink P, Larocca RA, De La Barrera RA, Bricault CA, Moseley ET, Boyd M, Kirilova M, Li Z, Ng'ang'a D, Nanayakkara O et al..  2016.  Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys.. Science. 353(6304):1129-32.
Barouch DH, Ghneim K, Bosche WJ, Li Y, Berkemeier B, Hull M, Bhattacharyya S, Cameron M, Liu J, Smith K et al..  2016.  Rapid Inflammasome Activation following Mucosal SIV Infection of Rhesus Monkeys.. Cell. 165(3):656-67.
Ho IY, Bunker JJ, Erickson SA, Neu KE, Huang M, Cortese M, Pulendran B, Wilson PC.  2016.  Refined protocol for generating monoclonal antibodies from single human and murine B cells.. J Immunol Methods. 438:67-70.
Barton JP, Goonetilleke N, Butler TC, Walker BD, McMichael AJ, Chakraborty AK.  2016.  Relative rate and location of intra-host HIV evolution to evade cellular immunity are predictable.. Nat Commun. 7:11660.
Voss JE, Macauley MS, Rogers KA, Villinger F, Duan L, Shang L, Fink EA, Andrabi R, Colantonio AD, Robinson JE et al..  2016.  Reproducing SIVΔnef vaccine correlates of protection: trimeric gp41 antibody concentrated at mucosal front lines.. AIDS. 30(16):2427-2438.
Klasse PJ, Labranche CC, Ketas TJ, Ozorowski G, Cupo A, Pugach P, Ringe RP, Golabek M, van Gils MJ, Guttman M et al..  2016.  Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C.. PLoS Pathog. 12(9):e1005864.
Escolano A, Steichen JM, Dosenovic P, Kulp DW, Golijanin J, Sok D, Freund NT, Gitlin AD, Oliveira T, Araki T et al..  2016.  Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice.. Cell. 166(6):1445-1458.e12.
Reese TA, Bi K, Kambal A, Filali-Mouhim A, Beura LK, Bürger MC, Pulendran B, Sekaly R-P, Jameson SC, Masopust D et al..  2016.  Sequential Infection with Common Pathogens Promotes Human-like Immune Gene Expression and Altered Vaccine Response.. Cell Host Microbe. 19(5):713-9.
Gautam R, Nishimura Y, Pegu A, Nason MC, Klein F, Gazumyan A, Golijanin J, Buckler-White A, Sadjadpour R, Wang K et al..  2016.  A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges.. Nature. 533(7601):105-9.
Baxter AE, Niessl J, Fromentin R, Richard J, Porichis F, Charlebois R, Massanella M, Brassard N, Alsahafi N, Delgado G-G et al..  2016.  Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals.. Cell Host Microbe. 20(3):368-80.
McGuire AT, Gray MD, Dosenovic P, Gitlin AD, Freund NT, Petersen J, Correnti C, Johnsen W, Kegel R, Stuart AB et al..  2016.  Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice.. Nat Commun. 7:10618.
Kleinsteuber K, Corleis B, Rashidi N, Nchinda N, Lisanti A, Cho JL, Medoff BD, Kwon D, Walker BD.  2016.  Standardization and quality control for high-dimensional mass cytometry studies of human samples.. Cytometry A. 89(10):903-913.
Halldorsson S, Behrens A-J, Harlos K, Huiskonen JT, Elliott RM, Crispin M, Brennan B, Bowden TA.  2016.  Structure of a phleboviral envelope glycoprotein reveals a consolidated model of membrane fusion.. Proc Natl Acad Sci U S A. 113(26):7154-9.
Tam HHei, Melo MB, Kang M, Pelet JM, Ruda VM, Foley MH, Hu JK, Kumari S, Crampton J, Baldeon AD et al..  2016.  Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination.. Proc Natl Acad Sci U S A. 113(43):E6639-E6648.
Nakaya HI, Clutterbuck E, Kazmin D, Wang L, Cortese M, Bosinger SE, Patel NB, Zak DE, Aderem A, Dong T et al..  2016.  Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood.. Proc Natl Acad Sci U S A. 113(7):1853-8.
Briney B, Sok D, Jardine JG, Kulp DW, Skog P, Menis S, Jacak R, Kalyuzhniy O, de Val N, Sesterhenn F et al..  2016.  Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies.. Cell. 166(6):1459-1470.e11.
Bancroft T, Dillon MBC, Antunes Rda Silva, Paul S, Peters B, Crotty S, Arlehamn CSLindesta, Sette A.  2016.  Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood.. Cell Immunol. 304-305:35-43.
Feng Y, Tran K, Bale S, Kumar S, Guenaga J, Wilson R, de Val N, Arendt H, DeStefano J, Ward AB et al..  2016.  Thermostability of Well-Ordered HIV Spikes Correlates with the Elicitation of Autologous Tier 2 Neutralizing Antibodies.. PLoS Pathog. 12(8):e1005767.
Halper-Stromberg A, Nussenzweig MC.  2016.  Towards HIV-1 remission: potential roles for broadly neutralizing antibodies.. J Clin Invest. 126(2):415-23.
Harvey DJ, Scarff CA, Edgeworth M, Struwe WB, Pagel K, Thalassinos K, Crispin M, Scrivens J.  2016.  Travelling-wave ion mobility and negative ion fragmentation of high-mannose N-glycans.. J Mass Spectrom. 51(3):219-35.
Harvey DJ, Scarff CA, Edgeworth M, Pagel K, Thalassinos K, Struwe WB, Crispin M, Scrivens JH.  2016.  Travelling-wave ion mobility mass spectrometry and negative ion fragmentation of hybrid and complex N-glycans.. J Mass Spectrom.
Stewart-Jones GBE, Soto C, Lemmin T, Chuang G-Y, Druz A, Kong R, Thomas PV, Wagh K, Zhou T, Behrens A-J et al..  2016.  Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G.. Cell. 165(4):813-26.
Kong L, He L, de Val N, Vora N, Morris CD, Azadnia P, Sok D, Zhou B, Burton DR, Ward AB et al..  2016.  Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability.. Nat Commun. 7:12040.

Pages